29 December 17
The Straits Times by RAFFAELLA NATHAN CHARLES
There are more ways to fold proteins than there are atoms in the universe, says Assistant Professor Chester Drum of the National University of Singapore's Yong Loo Lin School of Medicine.
But the assistant professor from the medicine and biochemistry departments has figured out a first - a way to fold a protein using a highly stable shell which wraps around the unfolded substrate, moulding ...more
27 December 17
The Straits Times by JEFFREY FUNK FOR THE STRAITS TIMES
Singapore's biotech sector has attracted many international manufacturers and its institutions work with many of them to address local health concerns such as Type 2 diabetes. These public-private partnerships also help companies connect with Singaporean academics and researchers.
As public concern grows over the direction of the biotech sector, especially following news of leadership changes ...more
31 October 17
The Business Times by CHIA YAN MIN
BRITISH pharmaceutical giant GSK officially opened its Asia headquarters here on Monday.
Called GSK Asia House, the facility in Rochester Park functions as the commercial hub for more than half of the company's global healthcare operations.
More than 800 employees work there, including the senior regional leadership teams of the pharmaceuticals, vaccines and consumer ...more
05 October 17
The Business Times by JUDITH TAN
GLOBAL research and development-based bio-pharmaceutical company AbbVie has enlarged its footprint in Singapore.
On Wednesday, it opened a new biologics manufacturing plant in Tuas, which will expand its manufacturing capabilities for biologics, which are commercial products derived from biotechnology. (Vaccines are one example.)
The biologics plant, located in ...more
06 September 17
The Straits Times by ANNABETH LEOW
A new scheme unveiled yesterday is primed to give drug-makers and the wider manufacturing sector a shot in the arm as disruptive change roils industries and poses huge challenges to bosses.
The initiative centres on bringing pharmaceutical giants together to jointly develop new technologies and enhance productivity.
Biomedical manufacturing is a key contributor to the overall manufacturing ...more
29 August 17
The Business Times
- Dr Loke Wai Chiong, healthcare sector leader, Deloitte South-east Asia; - Linus Tham, group chief information officer, Parkway Pantai; - Dr Tan Teck Jack, chairman & medical director, North-east Medical Group; - William Chew, managing director, myHealth Sentinel (mHS); - Adjunct associate professor Gamaliel Tan, chief medical informatics officer and head, Department ...more
28 August 17
The Business Times by CHAI HUNG YIN
US-BASED life science company Thermo Fisher Scientific, which produces life science instruments in Singapore for the global market, has expanded its presence in Asia-Pacific and emerging markets in the last few years to more than 20 per cent of the total global revenue.
Ravi Shastri, Thermo Fisher Scientific's vice-president and general manager of South-east Asia and Taiwan, ...more
25 August 17
The Business Times by SYARAFANA SHAFEEQ
GLAXOSMITHKLINE (GSK) Consumer Healthcare wants to know what consumers want - why they make the choices they do while shopping and what influences those choices.
To this end, the pharmaceutical giant on Thursday unveiled a Shopper Science Lab, kitted out with technology - hardware and software for eye-tracking, facial biometrics and data visualisation.
With the ...more
22 August 17
The Straits Times by SHAYNA TOH
Scientists here have discovered a chemical compound in mice that prevents heart muscle cells from repairing themselves. If it can be blocked, heart muscle cells can regenerate, like skin cells, and the heart may be able to heal itself.
With cardiovascular disease accounting for almost 20 per cent of all deaths here, researchers from the Agency for Science, Technology and Research's Genome ...more
29 July 17
The Straits Times by LIM CHUAN POH FOR THE STRAITS TIMES
On May 24, a local biotechnology company successfully raised US$33 million (S$44.8 million) through an initial public offering on the Taipei Exchange (TPEx), valuing the company at US$300 million.
This went largely unnoticed by most of Singapore, but caused ripples of excitement throughout the local biotech and research circles.
The company that listed on the TPEx was none other ...more
25 July 17
The Straits Times by SAMANTHA BOH
The Genome Institute of Singapore (GIS) has launched a new laboratory that will help provide customised, cutting-edge treatment for cancer patients.
The lab - set up in partnership with local healthcare bioanalytic firm Invitrocue - will develop models of cancerous tumours using cells from patients, and utilise tech tools like artificial intelligence and data mining to trawl through genetic ...more
22 July 17
The Business Times
THE JCS group of companies, which is among the winners of the SME100 awards this year was founded 27 years ago in 1990 by Jason Yeo and includes companies that provide products and solutions for the technology, biotech, renewable energy, aerospace, healthcare and consumer markets.
The focal companies for the award were BioCair, a market-leading non-toxic disinfectant used by hospitals, clinics, ...more
07 July 17
The Straits Times by FELICIA CHOO
A new cancer centre will be built at Biopolis, in Buona Vista, and open in stages from next year.
Called the Advanced Medicine Oncology Centre, it will provide imaging, treatment delivery, and clinical informatics technologies for healthcare professionals and researchers.
It is a collaboration between Royal Philips, the Singapore Institute of Advanced Medicine Holdings (SAM), Varian ...more
07 July 17
The Straits Times
Conference on gene mutation
Over 300 international scientists will gather in Singapore to share their latest findings on p53, the most common gene mutation in cancer.
Known as the "guardian of the genome", p53 works as a major tumour suppressor which defends cells in the body from any form of stress, including radiation, preventing them from becoming cancerous.
However, when mutated, ...more
29 June 17
The Business Times by JUDITH TAN
SCIENTISTS are now a step closer to turning cancer patients' own immune cells (T-cells) against the tumours in their bodies - and possibly finding a cure for the dreaded disease.
A Singapore-based biotechnology firm has emerged ahead of the very crowded research field of T-cell immunotherapy, by conducting the world's first US Food and Drug Administration (FDA) Phase Three ...more